Clinical Trial Update: Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Pancreatic Cancer [EARLY_Phase 1]

View source ↗

Summary

Pilot Phase 1 study evaluating an implantable microdevice to assess in situ drug response in pancreatic cancer patients. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Northwell Health | Conditions: Pancreatic Cancer | EARLY_Phase 1 | Status: RECRUITING